本页面由Tiger Trade Technology Pte. Ltd.提供服务

Entrada Therapeutics, Inc.

4.86
-0.6400-11.64%
盘后:4.910.0500+1.03%16:39 EDT
成交量:25.52万
成交额:127.41万
市值:1.89亿
市盈率:-1.22
高:5.56
开:5.50
低:4.83
收:5.50
52周最高:16.45
52周最低:4.83
股本:3,882.06万
流通股本:2,554.82万
量比:0.92
换手率:1.00%
股息:- -
股息率:- -
每股收益(TTM):-3.9676
每股收益(LYR):-3.4746
净资产收益率:-54.09%
总资产收益率:-29.20%
市净率:0.81
市盈率(LYR):-1.40

数据加载中...

2024/04/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/13

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/13

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/13

重要事件披露

Form 8-K - Current report
2024/03/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/03

重要事件披露

Form 8-K - Current report
2023/12/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities